Regulation of transcription of MHC class II genes

Current Opinion in Immunology

Volumn 9, Issue 1, 1997, Pages 107-113

  Boss, Jeremy M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; GENE CONTROL; HISTOCOMPATIBILITY GENE; HUMAN; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN DNA BINDING; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0031050035     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80166-5     Document Type: Article

References (57)

1. Kappes D, Strominger JL. Human class II major histocompatibility complex genes and proteins. Annu Rev Biochem. 57:1988;991-1028.
2. Latron F, Jotterand-Bellomo M, Maffei A, Scarpellino L, Bernard M, Strominger JL, Accolla RS. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc Natl Acad Sci USA. 85:1988;2229-2233.
3. Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, Ault KA, Gimbrone MA Jr, Strominger JL, Pober JS. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA. 81:1984;4917-4921.
4. De Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, De Vries JE. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol. 151:1993;6370-6380.
5. Lu H-T, Riley JL, Babcock GT, Huston M, Stark GR, Boss JM, Ransohoff RM. IFN-β acts downstream of IFN-induced CIITA mRNA accumulation to block MHC class II gene expression and requires the 48 kD DNA binding protein, ISGF3-γ of special interest J Exp Med. 182:1995;1517-1525 Describes additional level of class II expression that occurs in the presence of the essential MHC class II regulatory factor CIITA. Previous work had suggested that MHC class expression was limited solely by CIITA.
6. Reimold AM, Kara CJ, Rooney JW, Glimcher LH. Transforming growth factor-β1 repression of the HLA-DRα gene is mediated by conserved proximal promoter elements. J Immunol. 151:1993;4173-4182.
7. Brown AM, Wright KL, Ting JP-Y. Human major histocompatibility complex class II-associated invariant chain gene promoter. Functional analysis and in vivo protein/DNA interactions of constitutive and IFN-induced expression. J Biol Chem. 268:1993;26328-26333.
8. Kern I, Steimle V, Siegrist C, Mach B. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int Immunol. 7:1996;1295-1299.
9. Chang C-H, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med. 181:1995;765-767.
10. Griscelli C, Lisowska Grospierre B, Mach B. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic Rev. 1:1989;135-153.
11. Benichou B, Strominger JL. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci USA. 88:1991;4285-4288.
12. Seidl C, Saraiya C, Osterweil Z, Fu YP, Lee JS. Genetic complexity of regulatory mutants defective for HLA class II expression. J Immunol. 148:1992;1576-1584.
13. Sloan JH, Hasegawa SL, Boss JM. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. J Immunol. 148:1992;2591-2599.
14. Reith W, Satola S, Herreo-Sanchez C, Amaldi I, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell. 53:1988;897-906.
15. Hasegawa SL, Riley JL, Sloan JH, Boss JM. Protease treatment of nuclear extracts distinguishes between class II major histocompatibility complex X1 box DNA-binding proteins in wild type and class II deficient B cells. J Immunol. 150:1993;1781-1793.
16. Herrero-Sanchez C, Reith W, Silacci P, Mach B. The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol Cell Biol. 12:1992;4076-4083.
17. Durand B, Kobr M, Reith W, Mach B. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol Cell Biol. 14:1994;6839-6847.
18. Steimle V, Durand B, Emmanuele B, Zufferey M, Hadam MR, Mach B, Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). of outstanding interest Genes Dev. 9:1995;1021-1032 This paper describes the cloning of a gene (RFX5) encodong one of the subunits of RFX. Mutations in RFX5 are responsible for some, but not all, of the cases of the bare lymphocyte syndrome.
19. Emery P, Durand B, Mach B, Reith W. RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. of special interest Nucleic Acids Res. 24:1996;307-803 The molecular basis for the similarity of the RFX family of proteins is presented. This similarity shows that the RFX DNA binding domain is a common structure motif that is utilized across species.
20. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class II transcription. Paul WE, Garrision Fathman C, Metzger H. Annual Reviews of Immunology. 1992;13-50 Annual Reviews Inc, Palo Alto.
21. Hasegawa SL, Boss JM. Two distinct B cell factors bind the HLA-DRA X box region and recognize different subsets of MHC class II promoters. Nucleic Acids Res. 19:1991;6269-6276.
22. Moreno CS, Emery P, West JE, Durand B, Reith W, Mach B, Boss JM. Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX the X box factor deficient in the bare lymphocyte syndrome. of special interest J Immunol. 155:1995;4313-4321 Defines X2BP as the X2 box factor by showing cooperative interactions with RFX and X box DNA.
23. Reith W, Kobr M, Emery P, Durand B, Siegrist C-A, Mach B. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J Biol Chem. 269:1994;20020-20025.
24. Ivashkiv LB, Glimcher LH. Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements. J Exp Med. 174:1991;1583-1592.
25. Sinha S, Maity SN, Lu J, De Crombrugghe B. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc Natl Acad Sci USA. 92:1995;1624-1628.
26. Ronchi A, Bellorini M, Mongelli N, Mantovani R. CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA. Nucleic Acids Res. 23:1995;4565-4572.
27. Zeleznik-Le NJ, Azizkhan JC, Ting JP-Y. Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA. 88:1991;1873-1877.
28. Reith W, Siegrist CA, Durand B, Barras E, Mach B. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci USA. 91:1994;554-558.
29. Reith W, Steimle V, Mach B. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol Today. 16:1995;539-546.
30. Vilen BJ, Cogswell JP, Ting JP-Y. Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function. Mol Cell Biol. 11:1991;2406-2415.
31. Thanos D, Maniatis T. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell. 83:1995;1091-1100.
32. Tsang SY, Nakanishi M, Peterlin BM. Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol Cell Biol. 10:1990;711-719.
33. Vilen BJ, Penta JF, Ting JP-Y. Structural constraints within a trimeric transcriptional regulatory region. Constitutive and interferon-inducible expression of the HLA-DRA gene. J Biol Chem. 267:1992;23728-23734.
34. Jabrane-Ferrat N, Fontes JD, Boss JM, Peterlin BM. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol Cell Biol. 16:1996;4683-4690.
35. Kara CJ, Glimcher LH. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science. 252:1991;709-712.
36. Riley JL, Boss JM. Class II MHC transcriptional mutants are defective in higher order complex formation. J Immunol. 151:1993;6942-6953.
37. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (bare lymphocyte syndrome). Cell. 75:1993;135-146.
38. Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). of special interest Immunity. 2:1995;533-543 A functional characterization of CIITA is presented. CIITA was found to possess a strong transcriptional activation domain, suggesting that it may regulate class II genes as a transcriptional co-activator by interacting with factors bound to the X box region.
39. Zhou H, Glimcher LH. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. of special interest Immunity. 2:1995;545-553 See annotation [38].
40. Chang C-H, Fontes JD, Peterlin BM, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med. 180:1994;1367-1374.
41. Steimle V, Siegrist C-A, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science. 265:1994;106-108.
42. Chin K-C, Mao C, Skinner C, Riley JL, Wright KL, Moreno CS, Stark GR, Boss JM, Ting JP-Y. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity. 1:1994;687-697.
43. Lee YJ, Lu HT, Nguyen V, Qin H, Howe PH, Rogers E, Boss JM, Ransohoff RM, Benveniste EN. Transforming growth factor-β supresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator mRNA expression. J Immunol. 1996;. in press.
44. Silacci P, Mottet A, Steimle V, Reith W, Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med. 180:1994;1329-1336.
45. Sherman PA, Basta PV, Heguy A, Wloch MK, Roeder RG, Ting JP-Y. The octamer motif is a B-lymphocyte-specific regulatory element of the HLA-DRα gene promoter. Proc Natl Acad Sci USA. 86:1989;6739-6743.
46. Voliva CF, Jabrane-Ferrat N, Peterlin BM. The function of the octamer-binding site in the DRA promoter. Immunogenetics. 43:1996;20-26.
47. Wright KL, Ting JP-Y. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma. Proc Natl Acad Sci USA. 89:1992;7601-7605.
48. Abdulkadir SA, Krishna S, Thanos D, Maniatis T, Strominger JL, Ono SJ. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J Exp Med. 182:1995;487-500.
49. Stimac E, Lyons S, Pious D. Transcription of HLA class II genes in the absence of B-cell-specific octamer-binding factor. Mol Cell Biol. 8:1988;3734-3739.
50. Du W, Maniatis T. The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms. Proc Natl Acad Sci USA. 91:1994;11318-11322.
51. Thanos D, Maniatis T. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell. 71:1992;777-789.
52. Gstaiger M, Knoepfel L, Georgiev O, Schaffner W, Hovens CM. A B-cell coactivator of octamer-binding transcription factor. Nature. 373:1995;360-362.
53. Stubin M, Newell JW, Matthias P. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell. 80:1995;497-506.
54. Fontes JD, Jabrane-Ferrat N, Toth CR, Peterlin BM. Binding and cooperative interactions between two B cell-specific transcriptional coactivators. of outstanding interest J Exp Med. 183:1996;2517-2521 Describes first direct interactions of CIITA with another protein, Bob1, another transcriptional activator. The results of this paper suggest that multiple transcriptional co-activators may be required for maximal class II expression.
55. Brown JA, He X-F, Westerheide SD, Boss JM. Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5. Immunogenetics. 43:1995;88-91.
56. Chang C, Guerder S, Hong S, Van Ewijk W, Flavell R. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. of outstanding interest Immunity. 4:1996;167-178 Knockout of CIITA in mice results in a similar phenotype to BLS patients. Also, low levels of class II expression in thymus epithelium were evident, suggesting the possibility of an alternative CIITA independent mechanism of regulation.
57. Douhan J III, Hauber I, Eibl MM, Glimcher LH. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D α and β chains. of special interest J Exp Med. 183:1996;1063-1069 A novel mutation in class II gene regulation in which genes oriented in one direction on the chromosome are not expressed is described. Understanding this mutation may tie the effects of chromatin assembly and class II regulation together.